Tensec | $12,000,000 | (Jun 19, 2025)
Grifin | $11,000,000 | (Jun 19, 2025)
Materna Medical | $20,000,000 | (Jun 19, 2025)
Infinity Bio, Inc.
United States
- Baltimore, Maryland
- 19/06/2025
- Series A
- $8,000,000
Infinity Bio is a technology company that provides detailed insights into the immune system using its proprietary antibody profiling platform. The company’s core technology comprehensively measures the antibody reactome, revealing the targets of individual immune responses against all known human viruses, human proteins (autoimmunity), and allergen proteins. Infinity's assay, MIPSA, was developed at Johns Hopkins University in Ben Larman's Lab of Precision Immunology. It builds off decades of work in the fields of genomics, proteomics, immunology, and bioinformatics. Our assay was engineered to enable best-in-class turnaround times and cost. With a team of experienced professionals and a state-of-the-art facility, we are poised to make a significant impact to research and for our customers.
- Industry Biotechnology Research
- Website https://www.infinitybio.com/
- LinkedIn https://www.linkedin.com/company/infinity-bio-inc/
NaroIQ | $6,500,000 | (Jun 19, 2025)
Polar | $9,860,072 | (Jun 19, 2025)
Darwix AI | $1,500,000 | (Jun 19, 2025)
HydroBlok | $6,000,000 | (Jun 19, 2025)
Orange Quantum Systems | $13,742,820 | (Jun 19, 2025)
Corvia Medical, Inc. | $55,000,000 | (Jun 18, 2025)
GetZoot | $6,000,000 | (Jun 18, 2025)
AthenaHQ | $2,200,000 | (Jun 18, 2025)